# CurvaFix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curvafix

- Industry: Medical Devices & Equipment
- Headquarters: Bellevue, US
- Website: www.curvafix.com
- Total disclosed funding: $38M
- Latest round: Series C (Jun 29, 2023)
- Investors on record: 4

## About

Based in the US, CurvaFix, Inc. operates as a medical device company, innovating in orthopedic solutions specifically targeting pelvic fracture treatments with its specialized implant technology.CurvaFix, Inc. was founded in 2013 in Bellevue, US, focusing on orthopedic solutions. The company has completed four deals, with the most recent deal occurring on June 29, 2023. It raised USD 24.28 mn in Series C funding led by MVM Partners, with additional investment from Sectoral Asset Management. The current valuation of CurvaFix is USD 55.38 mn. The company is co-led by CEOs Mark Foster and Steve Dimmer.CurvaFix, Inc. specializes in advanced orthopedic solutions, focusing on the treatment of pelvic fractures through its flagship product, the CurvaFix® IM Implant. This innovative intramedullary device is designed to conform to the pelvis's natural curvature, overcoming limitations of traditional straight-screw treatments. It provides flexibility during implantation and rigidity post-placement, enhancing stability and reducing pull-out risk for patients with pelvic fragility fractures. Orthopedic surgeons in the US are the primary users of the CurvaFix implant, utilized in various healthcare facilities and trauma centers.CurvaFix generates revenue through direct sales of its IM Implant to medical institutions and surgical centers. The company operates a B2B model, with hospitals and clinics purchasing the implant for surgical procedures. Revenue is driven by the adoption of the CurvaFix IM Implant among orthopedic surgeons treating pelvic fractures, reflecting procedure volumes. Although specific pricing for the implant is undisclosed, it typically aligns with industry standards, where hospitals negotiate based on agreements or volume contracts, positioning the company well within the advanced surgical implant market.In June 2023, CurvaFix, Inc. raised USD 24.28 mn in Series C funding to support the introduction of the CurvaFix® IM Implant to the market and expand its business reach. The company aims to launch new products and expand into additional geographic markets, enhancing its presence in the orthopedic sector.

## Funding rounds

- Series C, Jun 29, 2023, $24M — MVM Partners, Sectoral Asset Management
- Series B, Jul 21, 2020, $11M — Sectoral Asset Management, Delta Dental of Washington
- Series A, Jun 6, 2018, $2.5M — SWAN Venture Fund

## Investors

- SWAN Venture Fund (https://capitalatlas.ai/funds/swan-venture-fund) — Series A
- Sectoral Asset Management (https://capitalatlas.ai/funds/sectoral-asset-management) — Series B, Series C
- Delta Dental of Washington — Series B
- MVM Partners (https://capitalatlas.ai/funds/mvm-partners) — Series C